Edit |   |
---|---|
Product Name | MK-2206 |
Description | MK-2206 is a small molecule which can act as an Akt inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: Cell cycle, Carbohydrate metabolism, Apoptosis inducer, AKT. This product may be of interest in the following research areas and diseases: Cell death, Cancer. This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV-2 in cells. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 480.39 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | MK-2206, 8-(4-(1-Aminocyclobutyl)phenyl-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one dihydrochloride, 1032350-13-2 |
Gene, Accession, CAS # | CAS: 1032350-13-2 |
Catalog # | abx283110 |
Price | please inquire |
Order / More Info | MK-2206 from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950